Kovack Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $400K | Sell |
4,818
-541
| -10% | -$44.9K | 0.04% | 387 |
|
|
2025
Q1 | $435K | Sell |
5,359
-787
| -13% | -$63.8K | 0.05% | 337 |
|
|
2024
Q4 | $553K | Buy |
6,146
+1,597
| +35% | +$144K | 0.05% | 286 |
|
|
2024
Q3 | $449K | Sell |
4,549
-705
| -13% | -$69.6K | 0.05% | 328 |
|
|
2024
Q2 | $487K | Buy |
5,254
+1,292
| +33% | +$120K | 0.05% | 306 |
|
|
2024
Q1 | $376K | Sell |
3,962
-2,257
| -36% | -$214K | 0.05% | 307 |
|
|
2023
Q4 | $555K | Sell |
6,219
-10,025
| -62% | -$895K | 0.07% | 278 |
|
|
2023
Q3 | $1.19M | Buy |
16,244
+1,422
| +10% | +$104K | 0.17% | 130 |
|
|
2023
Q2 | $1.23M | Buy |
14,822
+11,404
| +334% | +$949K | 0.16% | 134 |
|
|
2023
Q1 | $260K | Buy |
+3,418
| New | +$260K | 0.04% | 444 |
|
|
2022
Q3 | – | Sell |
-11,112
| Closed | -$825K | – | 626 |
|
|
2022
Q2 | $825K | Buy |
+11,112
| New | +$825K | 0.11% | 203 |
|
|
2017
Q1 | – | Sell |
-3,667
| Closed | -$217K | – | 310 |
|
|
2016
Q4 | $217K | Buy |
+3,667
| New | +$217K | 0.1% | 219 |
|